Skip to main content
PMC home page
Cell Death & Disease logoLink to Cell Death & Disease
. 2017 Jan 12;8(1):e2545. doi: 10.1038/cddis.2016.463

Impaired embryonic development in glucose-6-phosphate dehydrogenase-deficient Caenorhabditis elegans due to abnormal redox homeostasis induced activation of calcium-independent phospholipase and alteration of glycerophospholipid metabolism

Tzu-Ling Chen 1,2,10, Hung-Chi Yang 2,3,10, Cheng-Yu Hung 3, Meng-Hsin Ou 2, Yi-Yun Pan 2, Mei-Ling Cheng 1,3,4,5,6,7, Arnold Stern 8, Szecheng J Lo 7,*, Daniel Tsun-Yee Chiu 1,2,3,6,9,*
PMCID: PMC5386372  PMID: 28079896

Abstract

Glucose-6-phosphate dehydrogenase (G6PD) deficiency is a commonly pervasive inherited disease in many parts of the world. The complete lack of G6PD activity in a mouse model causes embryonic lethality. The G6PD-deficient Caenorhabditis elegans model also shows embryonic death as indicated by a severe hatching defect. Although increased oxidative stress has been implicated in both cases as the underlying cause, the exact mechanism has not been clearly delineated. In this study with C. elegans, membrane-associated defects, including enhanced permeability, defective polarity and cytokinesis, were found in G6PD-deficient embryos. The membrane-associated abnormalities were accompanied by impaired eggshell structure as evidenced by a transmission electron microscopic study. Such loss of membrane structural integrity was associated with abnormal lipid composition as lipidomic analysis revealed that lysoglycerophospholipids were significantly increased in G6PD-deficient embryos. Abnormal glycerophospholipid metabolism leading to defective embryonic development could be attributed to the increased activity of calcium-independent phospholipase A2 (iPLA) in G6PD-deficient embryos. This notion is further supported by the fact that the suppression of multiple iPLAs by genetic manipulation partially rescued the embryonic defects in G6PD-deficient embryos. In addition, G6PD deficiency induced disruption of redox balance as manifested by diminished NADPH and elevated lipid peroxidation in embryos. Taken together, disrupted lipid metabolism due to abnormal redox homeostasis is a major factor contributing to abnormal embryonic development in G6PD-deficient C. elegans.

The housekeeping gene glucose-6-phosphate dehydrogenase (G6PD), which is ubiquitously present in prokaryotic and eukaryotic organisms, encodes the rate-limiting enzyme in the pentose phosphate pathway. The importance of G6PD lies in the production of nicotinamide adenine dinucleotide phosphate (NADPH), which maintains intracellular redox homeostasis by regenerating glutathione in its reduced form.1 This is critical for negating the deleterious effects caused by excess oxidants including free radicals. NADPH is also required for the production of free radicals mediated by nitric oxide synthase and NADPH oxidase.2

Over 400 million individuals are inflicted by G6PD deficiency (favism) worldwide.3 A majority of G6PD mutations belong to single base missense mutation.4 The lack of reports on frameshift mutations or large deletions in this deficiency implies that complete loss of function of G6PD is incompatible with embryonic life.5, 6 Consistent with the report of embryonic lethality in G6PD-deficient mice, G6PD-deficient Caenorhabditis elegans displays impaired embryonic development indicated by severe hatching defects of embryos.7

Embryonic cell death induced by G6PD deficiency has been attributed to increased oxidative stress. G6PD-deficient embryonic stem cells fail to survive during oxidative stress.8, 9, 10 G6PD-knockout mice show embryonic arrest and death which is caused by oxidative damage.5 G6PD-knockdown zebrafish elicit embryonic defects and display enhanced oxidative stress-induced hemolysis upon treatment of pro-oxidants.11 These findings indicate an antioxidant role of G6PD during embryonic development. NADPH is also required for reductive biosynthesis, such as fatty acid synthesis and modification, during embryogenesis.12, 13 Lipids are essential in embryogenesis, and for example, perturbation in the regulation of membrane lipid metabolism causes early embryonic lethality in mouse.14, 15 How altered oxidative stress may affect lipid metabolism has largely been overlooked during embryonic development in G6PD-deficient organisms.

Lipidomics is a new omic technique aiming to globally analyze lipid species in a biological system. Such an approach can yield valuable information pertaining to the roles of lipids and establish metabolic pathways or networks that correlate with specific patho-physiological conditions.16 Phosphatidylcholine (PC) and phosphatidylethanolamine (PE) are the most abundant phospholipid species in eukaryotic cells, which account for more than half of the total phospholipids in eukaryotic membranes. Proper phospholipid composition is the key to establish and maintain the integrity of membrane structure and function. Phospholipids can be hydrolyzed by phospholipases, such as phospholipase A2 (PLA2).17 The PLA2 superfamily contains a diverse set of enzymes which cleave the sn-2 acyl bond of phospholipids and release a free fatty acid and a lysophospholipid. Both products of hydrolysis may produce second messengers that play essential roles in cellular signaling.18, 19, 20

We have made several novel discoveries. By using the cutting edge technology of lipidomics, we have demonstrated an abnormal lipid profile in G6PD-deficient C. elegans embryos with a marked increase in lysoglycerophospholipids. Such abnormal phospholipid composition is accompanied by the loss of membrane structural integrity as evidenced by electron microscopic studies and defective membrane properties, such as enhanced permeability, defective polarity and cytokinesis. Abnormal phospholipid metabolism associated with defective embryonic development could be attributed to the increased activity of calcium-independent phospholipase A2 (iPLA). This notion is corroborated by the partial rescue effect through the suppression of multiple iPLAs by genetic manipulation. Increased activity of iPLAs in G6PD-deficient embryos of C. elegans could be due to enhanced oxidative stress because diminished NADPH production and elevated lipid peroxidation have been detected in these embryos. This study provides the evidence for a potential mechanism of how G6PD deficiency causes embryonic lethality in C. elegans.

Results

Abnormal membrane function of embryos from G6PD-deficient C. elegans

Defective permeability of G6PD RNAi knockdown (Gi) embryos

Previously, we have established the G6PD-deficient C. elegans model by feeding wild-type C. elegans with Escherichia coli expressing RNA-mediated interference (RNAi) targeting G6PD gene7 and nearly all embryos derived from G6PD-deficient C. elegans failed to hatch.7 The morphology of G6PD-deficient embryos was examined by microscopy (Figure 1). Unlike normal embryos, G6PD-deficient embryos displayed irregular, flattened and an egg-filling phenotype, indicating that the structure of G6PD-deficient embryos may be influenced by osmotic changes (Figure 1a). In high-salt solution, G6PD-deficient embryos displayed dramatic shrinkage indicated by crenated blastomeres. To determine the developmental stage, isolated embryos were stained with Hoechst 33342. Fluorescent microscopic images showed that over half of G6PD-deficient embryos (53%) were permeable to Hoechst 33342, while mock embryos were completely impermeable to the dye (Supplementary Figure S1a). To validate the observation, G6PD-deficient embryos were stained with trypan blue and other fluorescent dyes, including Acridine orange, SYTO12 and FM4-64 (Supplementary Figures S1b–e). G6PD-deficient embryos were permeable to all fluorescent dyes but not trypan blue (Figure 1c), indicating that the permeability defect of G6PD-deficient embryos was limited to small-molecule dyes.

Figure 1.

Figure 1

Open in a new tab

The impact of G6PD deficiency on C. elegans embryo physiology. (a) The effect of G6PD knockdown on C. elegans embryo morphology under physiological condition (Egg buffer) and osmotic stress (Water, KCl). Representative DIC images of embryos derived from Mock and G6PD(RNAi)(Gi) C. elegans are shown. White scale bar indicates 10 μm. (b) The effect of G6PD knockdown and fatty acid synthase knockdown (Fasn-1(RNAi)) on permeability barrier formation in C. elegans embryos. Representative DIC and merged fluorescent images of two-cell embryos derived from Mock, Gi and Fasn-1(RNAi) of OD344 C. elegans are shown. In Mock embryo, the permeability barrier prevented the diffusion of red fluorescence (mCherry::CPG-2) to the surface of embryos (white arrow). The permeability barrier was disrupted in Gi embryos. Such inhibition caused the mCherry::CPG-2 to fill the space between the eggshell and embryo surface (white arrow head). Green fluorescence indicates the plasma membrane of the embryo. White scale bar indicates 10 μm. (c) List of dye permeability ratio in Mock and Gi embryos with different dyes (n>100 embryos/group)

Similar defective permeability of embryos from G6PD-deficient C. elegans and embryos from fatty acid synthase mutant C. elegans

Since the integrity of C. elegans eggshell and permeability barrier can be disrupted by metabolic alternations, such as inactivation of fatty acid synthesis, the permeability barrier in G6PD-deficient embryo was compared with fatty acid synthase-deficient embryo by using the permeability barrier reporter strain OD344 (mCherry::CPG-2;GFP::PH).21 The eggshell of a normal C. elegans embryo displayed a well defined structure, including an electron-dense thin outer vitelline layer, a middle chitin layer, a granule component layer, also known as chondroitin proteoglycan layer (CPG layer), and a perivitelline space.21 Inside the perivitelline space, the permeability barrier lies between the inner CPG layer and the plasma membrane. CPG-2 protein, extruded to the perivitelline space at the anaphase of meiosis I, is restricted outside the permeability barrier within the perivitelline space. The localization of mCherry::CPG-2 makes it a good fluorescent reporter for the integrity of the permeability barrier. The signal of mCherry::CPG-2 was detected at the circumference of the eggshell in normal embryo due to the intact permeability barrier, while mCherry::CPG-2 filled up the space between the eggshell and embryo plasma membrane in G6PD-deficient embryo (Figure 1b). This observation was similar to that observed in fatty acid synthase-deficient embryos. Fatty acid synthesis-derived permeability barrier formation has been demonstrated in the germline using the rrf-1(pk1417) mutant strain, where its germline RNAi is functional but the somatic RNAi is impaired.21 To determine whether the formation of permeability barrier modulated by G6PD occurred in somatic tissues or the germline, G6PD RNAi was performed in ppw-1(pk1425) mutant embryos that are sensitive to somatic RNAi, but resistant to germline RNAi. The results showed that half of G6PD-deficient embryos (51%) in the ppw-1(pk1425) background were permeable to Hoechst, while a portion of G6PD-deficient embryos (15%) in the rrf-1(pk1417) background were permeable to Hoechst, indicating that G6PD exerted broad effects on permeability mainly through somatic tissues with the germline playing a minor role.

A polarity defect of the two-cell stage of G6PD-deficient embryos

Phenotypes of G6PD-deficient embryos not only restricted to osmotic or permeability impairment, but also exhibited a polarity defect that was similar to mutants of fatty acid synthase having both polarity and osmotic defects (Figure 1b).13, 22 Embryos of wild-type N2 (n=33) and mock (n=32) showed normal first cell division, leading to a larger anterior cell (AB) and a smaller posterior cell (P1), indicating the asymmetric division. A subset of G6PD-deficient embryos (10%, n=60) had two daughter cells of equal size similar to fasn-1 and pod-2 mutants (33%, n=54), indicating symmetric division (polarity defect). As proper cell polarity plays a central role during early embryonic development, the early stage development of G6PD-deficient embryos was examined by time-lapse microscopy (Supplementary Figure S2). A large proportion of G6PD-deficient embryos (73%, n=45) showed the absence of cortical ruffling, pseudocleavage and an abnormal interaction of pro-nuclei with the cortex compared with mock embryos (summarized in Supplementary Table S1). Moreover, G6PD-deficient embryos took longer to develop or underwent embryonic arrest. These findings suggest that impairment in the beginning of embryogenesis was indicative of an early sign of embryonic lethality.

Abnormal eggshell ultrastructure of G6PD-deficient embryos by transmission electronic microscopy

Since structure and function always go hand in hand, transmission electron microscopy (TEM) was used to examine the ultrastructure of the eggshell in G6PD-deficient embryo (Figure 2). The eggshell of G6PD-deficient embryo displayed a thin outer vitelline layer and a middle chitin layer similar to the normal eggshell. Two key differences were found in the eggshell of G6PD-deficient embryo: increased width of the electron-dense layer inside the chitin layer (probably the CPG layer). Unlike normal eggshell surrounded by a substantial perivitelline space, G6PD-deficient embryo showed a dramatic absence of such structure indicated by the close proximity of the CPG layer and the plasma membrane. The phenomenon of compressed or disappeared perivitelline space in G6PD-deficient embryo observed by TEM was consistent with the egg-filling phenotype observed by DIC microscopy (Figures 1a and b). G6PD-deficient embryo showed an abnormal but unique eggshell ultrastructure clearly distinguishable from normal embryo eggshell, strongly suggesting a role for G6PD in maintaining the normal structure of the eggshell permeability barrier.

Figure 2.

Figure 2

Open in a new tab

G6PD deficiency disrupts eggshell structure in C. elegans embryo indicated by TEM. (a) Schematic drawing of a normal C. elegans embryo. Red box indicates a portion of eggshell structure shown in (b). (b) Color-coded cartoon of the normal eggshell structure shown in (c). (c) Representative TEM image of the Mock embryo eggshell structure. (d) Representative TEM image of G6PD-deficient embryo eggshell structure. Black scale bar in (c and d) indicates 0.2 μm

Altered lipid composition as shown by lipidomic analysis

Reliability of lipidomic analysis

Since fatty acid biosynthesis is critical during embryonic development in C. elegans13, 22, 23, 24 and G6PD-deficient embryos displayed altered function of their membranes, the latter could be attributed to altered membrane lipids during embryogenesis. A lipidomic approach was carried out (Figure 3a and Supplementary Figure S3) to investigate whether G6PD deficiency affects lipid metabolism in C. elegans. Replicates of adults and embryos generated clusters in the principle component analysis (PCA) plot, suggesting that the analysis was reliable (Supplementary Figure S4). The lipidomic data were confirmed by feeding C. elegans with different E. coli strains (Supplementary Figures S5a and b). Mock embryos derived from parents fed with E. coli HT115 (Mock/HT115) and wild-type embryos derived from parents fed with E. coli OP50 (WT/OP50) formed separate clusters (Supplementary Figure S5a). Clusters of Mock/HT115 and wild-type embryos derived from parents fed with E. coli HT115 (WT/HT115) partially overlapped in the PCA plot (Supplementary Figure S5b). These data show that the lipidomic approach can distinguish altered lipidomic responses in embryos upon changing the bacterial diet. It also indicates that the lipidomic response of the Mock(RNAi) diet is analogous to that of the wild type with the same diet.

Figure 3.

Figure 3

Open in a new tab

G6PD deficiency substantially increases lysoglycerophospholipids in C. elegans embryo as revealed by lipidomic analysis. (a) Workflow of lipidomic analysis. (b) The PCA plots of Mock, Gi and Fasn-1(RNAi) embryos in ESI+ and ESI− mode. (c) Comparison of lysoglycerophospholipids between Mock and Gi embryos in ESI+ mode. (d) Comparison of lysoglycerophospholipids between Mock and Gi adults in ESI+ mode. All fold change data are presented as the mean±S.D. and statistical significance was calculated using a two-tailed t-test (N=3, *P<0.05; **P<0.005; ***P<0.001)

Altered lipidomic profile of G6PD-deficient embryos

Since G6PD-deficient C. elegans embryos phenocopied mutant embryos of fatty acid synthesis, their lipidomic profiles were compared (Figure 3b). In the PCA plot, G6PD-deficient embryos were well separated from Mock embryos in both the ESI+ and ESI− modes. While fasn-1(RNAi) embryos were separated from Mock embryos in the ESI+ mode, it was closer to Mock embryos in the ESI− mode. These distinct lipidomic profiles suggest that G6PD deficiency may modulate an alternative lipid metabolic pathway.

Increased lysoglycerophospholipids in G6PD-deficient embryos

Glycerophospholipids were identified as the main lipid class in C. elegans embryos (Table 1 and Supplementary Tables S2 and S3). Among glycerophospholipids, lysoPC and lysoPE were significantly enhanced in G6PD-deficient embryos (Figure 3c and Supplementary Table S4) but less in G6PD-deficient adults (Figure 3d). Long-chain lysoPCs, ranging from lysoPC(16 : 0) to lysoPC(20 : 5), were increased by 2-to 6-fold in G6PD-deficient embryos. Long-chain lysoPEs were increased by 1.5- to 5.7-fold in G6PD-deficient embryos. In contrast, most of the PCs were reduced in G6PD-deficient embryos (Table 1). Similarly, ether plasmalogens as well as branched chain fatty acid containing PEs were decreased in G6PD-deficient embryos (Table 1). In fasn-1(RNAi) embryos, the majority of long-chain lysoPCs and lysoPEs remained relatively constant (Supplementary Tables S2 and S3). The fact that G6PD deficiency not only induced defective membrane structure and function in the eggshell but also changed glycerophospholipid compositions in the embryo suggests that these G6PD-deficiency-induced abnormalities are closely linked during embryonic development.

Table 1. Altered lipid metabolites in G6PD-deficient C. elegans embryos.
Compound category Identification m/z Formula RT (min) Mass error (Da) Fold change (Gi/Mock) P-value VIP score ESI
Glycerophospholipids LysoPC(15 : 0) 482.3256 C23H48NO7P 0.99 0.0015 1.63 <0.001 1.84 Positive
  LysoPC(16 : 0)a 496.3417 C24H50NO7P 1.17 0.0019 3.50 <0.001 2.37 Positive
  LysoPC(17 : 0) 510.3575 C25H52NO7P 1.31 0.0021 2.47 <0.005 2.10 Positive
  LysoPC(17 : 1) 508.3417 C25H50NO7P 1.10 0.0019 4.38 <0.001 2.28 Positive
  LysoPC(18 : 0) 524.3734 C26H54NO7P 1.60 0.0023 6.63 <0.001 2.43 Positive
  LysoPC(18 : 1) 522.3576 C26H52NO7P 1.21 0.0022 4.78 <0.001 2.28 Positive
  LysoPC(18 : 2) 520.3420 C26H50NO7P 1.00 0.0022 3.71 <0.005 2.27 Positive
  LysoPC(20 : 3) 546.3580 C28H52NO7P 1.08 0.0026 5.16 <0.001 2.31 Positive
  LysoPC(20 : 4)a 544.3418 C28H50NO7P 0.94 0.0020 3.19 <0.001 2.24 Positive
  LysoPC(20 : 5)a 542.3256 C28H48NO7P 0.84 0.0015 2.02 <0.05 1.49 Positive
  LysoPE(18 : 0) 482.3259 C23H48NO7P 1.69 0.0018 1.50 <0.005 1.68 Positive
  LysoPE(18 : 1)a 480.3108 C23H46NO7P 1.23 0.0023 4.37 <0.001 2.43 Positive
  LysoPE(18 : 2)a 478.3029 C23H44NO7P 1.05 0.0101 5.70 <0.05 2.37 Positive
  PC(19 : 1) 580.3636 C27H54NO7P 1.48 0.0016 5.53 <0.005 2.15 Negative
  PC(33 : 1) 746.5736 C47H84NO8P 6.35 0.0042 0.60 <0.001 2.06 Positive
  PC(33 : 1) 746.5728 C41H80NO8P 6.90 0.0034 1.20 <0.05 1.17 Positive
  PC(35 : 1) 774.6048 C43H84NO8P 9.17 0.0041 1.88 <0.005 1.99 Positive
  PC(35 : 1) 774.6046 C43H84NO8P 8.36 0.0039 0.60 <0.05 1.62 Positive
  PC(35 : 2) 772.5892 C43H82NO8P 6.76 0.0041 0.58 <0.001 1.81 Positive
  PC(35 : 2) 772.5892 C43H82NO8P 7.11 0.0041 0.85 <0.05 1.81 Positive
  PC(35 : 4) 768.5586 C43H78NO8P 4.93 0.0048 0.71 <0.05 1.79 Positive
  PC(35 : 5) 810.5307 C43H76NO8P 4.10 0.0016 0.74 <0.05 1.50 Negative
  PC(38 : 4) 810.6056 C46H84NO8P 7.22 0.0062 2.02 <0.001 2.32 Positive
  PC(38 : 5) 808.5906 C46H82NO8P 6.44 0.0055 1.74 <0.05 1.94 Positive
  PC(38 : 7) 848.5467 C46H78NO8P 4.08 0.0020 0.79 <0.05 1.20 Negative
  PC(38 : 8) 802.5426 C46H76NO8P 3.57 0.0045 0.63 <0.001 2.29 Positive
  PC(38 : 9) 800.5266 C46H74NO8P 3.08 0.0041 0.64 <0.001 2.04 Positive
  PC(39 : 5) 822.6067 C47H84NO8P 7.22 0.0060 0.51 <0.001 1.84 Positive
  PE(32 : 1) 690.5102 C37H72NO8P 6.19 0.0034 0.58 <0.001 2.37 Positive
  PE(33 : 1) 702.5096 C38H74NO8P 7.38 0.0017 0.86 <0.05 1.49 Negative
  PE(34 : 1) 718.5409 C39H76NO8P 8.19 0.0028 0.36 <0.001 2.20 Positive
  PE(34 : 2) 714.5089 C39H74NO8P 6.88 0.0010 0.62 <0.001 1.95 Negative
  PE(34 : 2) 716.5259 C39H74NO8P 6.94 0.0034 0.64 <0.001 2.12 Positive
  PE(35 : 1) 716.5620 C40H78NO7P 11.33 0.0031 0.24 <0.001 2.22 Positive
  PE(35 : 1) 718.5781 C40H80NO7P 12.72 0.0400 0.29 <0.001 2.12 Positive
  PE(36 : 1) 730.5782 C41H80NO7P 10.47 0.0037 0.23 <0.001 2.27 Positive
  PE(36 : 5) 736.4941 C41H72NO8P 5.18 0.0018 0.74 <0.05 1.42 Negative
  PE(37 : 1) 758.5732 C42H82NO8P 12.61 0.0027 1.13 <0.005 1.11 Negative
  PE(37 : 1) 746.6088 C42H84NO7P 13.02 0.0030 0.13 <0.001 2.33 Positive
  PE(37 : 2) 744.5934 C42H82NO7P 12.96 0.0032 0.11 <0.001 2.26 Positive
  PE(37 : 5) 752.5275 C42H74NO8P 5.77 0.0020 0.28 <0.001 1.85 Positive
  PE(37 : 5) 750.5092 C42H74NO8P 5.71 0.0013 0.45 <0.001 1.67 Negative
  PE(38 : 2) 756.5949 C43H82NO7P 12.61 0.0047 0.35 <0.001 2.07 Positive
  PE(P-36 : 1) or PE(O-36 : 2) 730.5777 C41H80NO7P 12.26 0.0032 0.34 <0.001 2.19 Positive
  PE(O-36 : 1) or PE(P-36 : 0) 732.5941 C41H82NO7P 12.61 0.0039 0.32 <0.001 2.03 Positive
  PE(P-36 : 2) or PE(O-36 : 3) 728.5625 C41H78NO7P 10.01 0.0036 0.51 <0.001 2.20 Positive
  PE(P-38 : 5) or PE(O-38 : 6) 748.5295 C43H76NO7P 7.78 0.0008 0.41 <0.001 1.88 Negative
                   
 
Glycerolipids TG(49 : 2) 834.7593 C52H96O6 15.31 0.0048 0.84 <0.05 1.70 Positive
  TG(50 : 3) 846.7602 C53H96O6 15.15 0.0057 0.77 <0.001 1.98 Positive
  TG(52 : 2) 876.8074 C55H102O6 15.69 0.0059 0.92 <0.05 2.01 Positive
  TG(53 : 2) 890.8234 C56H104O6 15.89 0.0063 1.27 <0.001 2.01 Positive
  TG(53 : 2) 895.7800 C58H104O6 15.89 0.0075 1.24 <0.005 1.85 Positive
  TG(55 : 6) 910.7956 C58H100O6 15.24 0.0098 2.12 <0.005 2.04 Positive
Open in a new tab

All metabolites in the list were verified by MS/MS in either ESI+ or ESI− modes

a

Confirmed by mass error. Others were confirmed by MS/MS and website database

Inverse correlation between PLA2 activity and G6PD activity in C. elegans embryos

Increased PLA2 activity in G6PD-deficient embryos

Based on the lipidomic analysis, it is postulated that during embryogenesis, G6PD regulates the activity of PLA2s, which are critical for organismal development.25, 26, 27, 28, 29 As iPLAs family was considered the main phospholipase in C. elegans,25 iPLA activity was determined (Figure 4a). Compared with mock, iPLA activity was increased in G6PD-deficient adults (2-fold, P<0.05) and even more so in G6PD-deficient embryos (10-fold, P<0.005). The iPLA activity of G6PD-deficient embryos was higher (3-fold, P<0.005) than that of G6PD-deficient adults. There was no significant difference (P>0.05) in the transcriptional level of iPLA in the adult, gonad or embryo between Mock and G6PD-deficient C. elegans (data not shown), indicating that G6PD deficiency stimulated iPLA protein activity. These results demonstrate that the iPLA activity was greatly enhanced in G6PD-deficient embryos and was consistent with the lipidomic data that lysoglycerophospholipids were dramatically altered in G6PD-deficient embryos (Figure 3c).

Figure 4.

Figure 4

Open in a new tab

iPLA activity in G6PD deficiency-induced embryonic lethality. (a) The iPLA activity was determined in Mock and Gi adults (N=3, *P<0.05) and embryos (N=7, **P<0.005)(##P<0.005, Gi embryos compared with Gi adults). (b) Effect of iPLA inhibition on brood size (N>3, n>60 worms/experiment, *P<0.05; **P<0.005; ***P<0.001)

Alleviation of embryonic defects by suppression of the iPLA genes in G6PD-deficient embryos

Since G6PD deficiency enhanced the iPLA activity, it is reasonable to test whether the downregulation of iPLA could rescue defective phenotypes of G6PD-deficient embryos. Knockdown of the single iPLA gene (ipla1, ipla2, ipla3) failed to rescue the defective phenotypes of G6PD-deficient embryos (Figure 4b and Table 2). C. elegans shows a high degree of redundancy among ipla gene members in the genome, suggesting that each ipla member is likely involved in the remodeling of phospholipids.25 To avoid the potential redundant effects of ipla genes, the combination of RNAi targeting multiple ipla genes were used. The knockdown of two ipla genes (ipla2 and ipla3) and three ipla genes (ipla1, ipla2 and ipla3) significantly increased the brood size of G6PD-deficient C. elegans (Figure 4b). Although the downregulation of ipla2 and ipla3 was insufficient to rescue the permeability defect caused by G6PD deficiency, knockdown of three ipla genes alleviated such permeability defect (Table 2). No polarity defect was seen upon knockdown of the two ipla genes or all three ipla genes in G6PD-deficient embryos (Table 2). The beneficial effects of inhibition of multiple ipla genes by RNAi in G6PD deficiency supports the notion that G6PD deficiency enhanced iPLA activity which in turn altered the glycero phospholipid metabolism and membrane integrity during embryogenesis.

Table 2. The effects of iPLA knockdown on permeability and polarity in C. elegans embryos.
Genotype Permeability (%) Polarity
mock 0.0 0/30
g6pd-1(RNAi) 53.3±6.08 4/30
ipla-1(RNAi) 0.0 0/30
ipla-1(RNAi); g6pd-1(RNAi) 58.0±11.36 3/30
ipla-2(RNAi) 0.0 0/31
ipla-2(RNAi); g6pd-1(RNAi) 56.7±9.61 2/20
ipla-3(RNAi) 0.0 0/30
ipla-3(RNAi); g6pd-1(RNAi) 49.7±1.53 1/20
ipla-2(RNAi); ipla-3(RNAi) 0.0 0/34
ipla-2(RNAi); ipla-3(RNAi); g6pd-1(RNAi) 50.3±5.51 0/22
ipla-1(RNAi); ipla-2(RNAi); ipla-3(RNAi) 0.0 0/34
ipla-1(RNAi); ipla-2(RNAi); ipla-3(RNAi); g6pd-1(RNAi) 16.0±1.73a 0/36
Open in a new tab
a

P<0.001compared with g6pd-1(RNAi)

Diminished NADPH production and association of increased iPLA activity with enhanced lipid peroxidation in G6PD-deficient embryos

Since PLA2 activity is associated with phospholipid peroxidation in cell membranes,30 the malondialdehyde (MDA) level was measured in embryos (Figure 5a). The MDA level was enhanced by 2-fold in G6PD-deficient embryos compared with mock embryos (Figure 5a). Such a finding is consistent with the observation that G6PD knockdown enhances oxidative stress and DNA oxidative damage in C. elegans.7 The level of NADP was not significantly altered (P=0.68) between Mock and G6PD-deficient adults (Figure 5b). However, the level of NADPH was decreased by 40% in G6PD-deficient adults compared with Mock adults. These findings indicate that G6PD deficiency disrupts redox homeostasis, thereby enhancing lipid peroxidation and activating phospholipase activity in C. elegans embryos.

Figure 5.

Figure 5

Open in a new tab

G6PD deficiency disrupts redox homeostasis by enhancing lipid peroxidation and reducing NADPH production. (a) Lipid peroxidation was determined in Mock and Gi embryos (N=4, *P<0.05). (b) NADPH and NADP levels were determined in Mock and Gi adults (N>3, *P<0.05)

Discussion

The novel findings in this study provide evidence to explain why G6PD-deficient C. elegans has impaired embryonic development indicated by severe hatching defects reported previously.7 Reduced NADPH production and enhanced lipid peroxidation are associated with increased iPLA activity in G6PD-deficient embryos. Inhibition of multiple iPLAs by genetic manipulation can alleviate the embryonic impairment caused by G6PD deficiency. Increased lysoglycerophospholipids, revealed by lipidomics, is found in G6PD-deficient embryos, leading to abnormal membrane defects and eventually embryonic lethality.

G6PD is essential for growth and development in cells and organisms. G6PD plays a critical role in rapidly proliferating cells such as that during tumorigenesis31, 32 and during embryonic development.5, 7, 11 G6PD-deficient yeasts are viable but defective in methionine production.33, 34 Expression of acetaldehyde dehydrogenase restores the methionine auxotrophy in G6PD-deficient yeast, presumably by providing NADPH.35 These findings corroborate the classical antioxidant role of G6PD by providing cellular reducing equivalents, namely NADPH.

NADPH plays two major roles in cellular physiology. On the one hand, NADPH is an essential reducing power to maintain intracellular redox homeostasis by regenerating glutathione in its reduced form, which is critical for negating deleterious effects caused by excess oxidants including free radicals. On the other hand, NADPH is also required for reductive biosynthesis, including lipid synthesis and modification enzymes, for example, fatty acid synthase and cytochrome p450 reductase (CYP) EMB-8.13 Fatty acid biosynthesis is crucial for decision-making processes during embryonic development in C. elegans.13, 21 G6PD-deficient embryos phenocopy the membrane defects of fatty acid synthase mutant (Figure 1b), suggesting that G6PD is linked to membrane lipid metabolism during embryonic development. This notion is confirmed by the lipidomic analysis showing that glycerophospholipids are the major class of lipids being altered in G6PD-deficient embryos.

Alteration of the lipid metabolism impairs animal physiology.36, 37 The composition of fatty acids in phospholipids affects membrane structure.38 C. elegans can de novo synthesize a variety of polyunsaturated fatty acids (PUFA) with 18–20 carbons or obtain them from bacterial diet.24 Lipidomic analysis revealed that a majority of PUFA-containing lysoglycerophospholipids were increased in G6PD-deficient embryos (Supplementary Tables S2 and S3). The presence of PUFA in lysoPCs is consistent with previous C. elegans studies.39, 40 C. elegans CYPs utilize PUFA to generate eicosanoids, which are required for early embryonic development. Depletion of C. elegans CYPs causes defective embryonic phenotypes, including osmotic sensitivity, dye permeability and abnormal formation of permeability barrier.13, 21 G6PD-deficiency-induced permeability defects are similar to the embryo lacking chitin synthase or CPGs.21 Assembly of the eggshell requires exocytosis of ECM-modifying proteins, also called cortical granules, which facilitate the separation of the vitelline layer from the embryo surface and creates the perivitelline space.41 Within the cargoes of cortical granules, the CPG-1/2 is required for the formation of the permeability barrier. This barrier, formed during the anaphase of meiosis II, is an impenetrable envelope between the eggshell and the plasma membrane.42 The assumption that G6PD deficiency disrupts the formation of the permeability barrier is corroborated by the altered localization of mCherry::CPG-2 (Figure 1b) and the disrupted the eggshell ultrastructure (Figure 2). These results provide additional support to the notion that G6PD is required for the establishment of the permeability barrier in early embryonic development.

The permeability barrier is important for completion of meiosis and the establishment of polarity. A portion of G6PD-deficient embryos displayed a polarity defect and altered cytokinesis (Figure 1b and Supplementary Table S1). G6PD-deficient embryos phenocopy the polarity defect of the C. elegans mutant lacking essential enzymes of the fatty acid biosynthesis pathways, including FASN-1 and POD-2, as well as the fatty acid-modifying pathway, such as CYP-31A2 or CYP31A3.13 This phenomenon indicates that G6PD is linked to the establishment of cell polarity mediated by fatty acid synthesis and modification during embryonic development. Proper fatty acid composition is of paramount importance because it not only maintains membrane tension or curvature but also fosters a distinct membrane domain (microdomain or lipid raft) necessary for facilitating the interaction between the complex of the pronucleus/centrosome and cortex. Since fatty acids and lipid compositions are meticulously regulated in a given cell or tissue during development,43 the altered fatty acid composition in glycerophospholipids of G6PD-deficient embryos strongly suggests that G6PD is closely associated with the glycerophospholipids metabolism during embryonic development.

PLA2 plays an important role in membrane glycerophospholipid remodeling. The strongly elevated iPLA activity in G6PD-deficient embryos is in line with the increased lysoglycerophospholipids indicated by the lipidomic analysis (Figure 4a and Table 1). The differential level of iPLA activation between G6PD-deficient adults and embryos suggests that G6PD modulates iPLA activity during embryogenesis. Such a notion is not unprecedented, as choline kinase, a mammalian enzyme which phosphorylates choline to phosphocholine which is needed for PC synthesis, is crucial for embryogenesis but not required in the adult physiology in mouse.15 Conditional knockout of group VIC iPLA2 (PNPLA6) causes neurodegeneration, while complete inactivation of this gene leads to embryonic lethality,44, 45 confirming that iPLA is involved in embryonic development. The suppression of multiple iPLAs in G6PD-deficient C. elegans partially rescued the embryonic defects. This genetic manipulation indicates a strong correlation between G6PD status and iPLA activity in embryonic development.

Cellular metabolism is highly responsive to oxidative stress.46, 47, 48 The activation of iPLA is associated with oxidative damages, such as oxidized phospholipids.49, 50 Lipid peroxidation-stimulated PLA2 cleaves peroxidized fatty acids as a first step to repair oxidized phospholipids in membranes.49, 50 Lipid peroxidation also activates phospholipase C (PLC) in the rat brain homogenate, while reactive oxygen species scavengers block PLC activity and downstream signaling.51 Lipid hydroperoxides and their derivatives change the physical properties of cell membranes by altering phospholipid structure, orientation and dynamics.52, 53 Perturbation of red cell membrane by t-butyl hydroperoxide alters membrane phospholipid composition and permeability function.54 Since G6PD deficiency induces oxidative stress and oxidative damage,6, 55 the imbalanced redox environment, represented by decreased NADPH and elevated MDA due to G6PD deficiency, is likely responsible for the increased activity of iPLA. Intriguingly, the reduced NADPH level was found in G6PD-deficient C. elegans, while increased lysoglycerophospholipids were detected in their embryos. We reason that the main consequence of reduced NADPH level under G6PD deficiency is the induction of excess oxidative stress, which is indicated by the elevated lipid peroxidation in the embryo. Such lipid oxidative damage directly activates iPLA, which leads to the degradation of a fraction of PC or PE. Glycerophospholipids, including PC and PE, are the most abundant phospholipid species in eukaryotic cells (accounts for more than 50%), while the lysoglycerophospholipids are very low (<2%) due to their deleterious effect on the cell membrane. Thus, the increase of lysoPC or lysoPE derived from PC or PE is dramatic in G6PD-deficient embryos.

Based on the evidence provided in this study, a scheme of G6PD deficiency-induced abnormal lipid metabolism leading to defective embryonic development in C. elegans is proposed (Figure 6). G6PD knockdown reduces NADPH production, which mainly impacts lipid metabolism through insufficient production of antioxidant capacity in embryos. As a result, elevated oxidized lipid products such as MDA and lipid peroxides in the zygote activate iPLA activity and generate excess production of lysoglycerophospholipids. Alternatively, decreased NADPH may modulate fatty acids synthesis through FASN-1 and possibly others such as CYPs. Together, disrupted lipid metabolism causes major structural and functional abnormalities of membranes leading to embryonic defects and eventually embryonic lethality.

Figure 6.

Figure 6

Open in a new tab

Proposed model of how G6PD deficiency causes embryonic lethality in C. elegans

Materials and methods

Nematode culture and RNAi silencing

N2 (wild type), pod-2(ye60), rrf-1(pk1417), ppw-1(pk1425) were acquired from Caenorhabditis Genetics Center (University of Minnesota, Minneapolis, MN, USA). The permeability barrier reporter strain OD344 was a gift from Prof. Sara Olson (Pomona College, Claremont, CA, USA). The nematode was propagated on a nematode growth medium (NGM) agar plate seeded with E. coli OP50 at 20 °C according to the standard protocols from Wormbook.56 For RNAi silencing experiments, synchronized L1 larvae by hypochlorite bleach were grown on NGM agar supplemented with 1 mM isopropyl-b-d-thiogalactopyranoside and antibiotics (ampicillin and carbenicillin) (Sigma-Aldrich, St Louis, MO, USA) and fed with HT115 E. coli harboring RNAi for silencing the specific gene target.57

Phenotype assays

The morphology of embryos was examined by using embryos dissected from day 1 adults followed by mounting on a 2% agarose pad on a glass slide. DIC and fluorescent images were taken by using Leica DM 2500 (Leica, Ernst-Leitz-Straße, Wetzlar, Germany). For the osmotic sensitivity assay, embryos were placed in water, egg buffer or 1 M potassium chloride for 1 h at room temperature. For the dye permeability assay, embryos were stained with 0.4% trypan blue or 10 g/ml fluorescent dyes (Sigma-Aldrich) in PBS in the dark for 30 min. For the permeability barrier assay, embryos in the genetic background of OD344 (mCherry::CPG-2; GFP::PH) were used. The integrity of the permeability barrier was determined by the localization of mCherry::CPG-2. To quantify polarity, the area of two daughter cells was analyzed by Image J (NIH, Bethesda, MD, USA). The polarity defect was defined as the area of the anterior cell less than 53% of total embryonic cells. For brood size measurement, the total number of viable F1 worms derived from RNAi-treated parents was determined. For the embryonic development determination, time-lapsed images of embryos were taken at room temperature by using Leica DM 2500 (Leica).

TEM

Gravid adults were frozen substituted in acetone (J.T. Baker, Phillipsburg, NJ, USA) containing 2% osmium tetroxide (Electron Microscopy Science, Hatfield, PA, USA) and 0.2% uranyl acetate (Electron Microscopy Science) in a Leica EM automatic freeze substitution machine (Leica). The temperature was raised from −90 °C to room temperature for 22 h (5 °C/h). The samples were dehydrated in 100% ethanol (Sigma-Aldrich) for 24 h, followed by two washes. The washed samples were embedded in the EMBed-812 embedding kit (Electron Microscopy Science) and incubated at 70 °C for 48 h. The 70 nm thin sections were cut by using a Reichert ultracut S microtome (Leica). Thin sections were collected on Formvar-coated copper grids (Electron Microscopy Science) and post-stained with 0.8% uranyl acetate (Electron Microscopy Science) in 40% methanol (J.T.Baker) followed by aqueous lead citrate (Electron Microscopy Science). Thin sections were viewed in a JEM-1230 transmission electron microscope (JEOL, Akishima, Tokyo, Japan).

Lipidomic analysis

Replicates of C. elegans adult bearing eggs were washed off NGM plates by ultra water. The samples were lysed with bleach reagents (0.5 M NaOH and 1% NaOCl) for 5 min followed by wash with M9 buffer and centrifugation for three times. The mixture was filtered through a 12 × 75 mm BD Falcon cell-strainer cap (BD Biosciences, San Jose, CA, USA), centrifuged at 2500  r.p.m. for 5 min (Eppendorf, Hamburg, Germany) and washed with cold PBS for three times. Embryos were then subjected to lipid extraction using the Folch method.58 Lipidomic analysis was carried out using ultra-performance liquid-chromatography (UPLC) system (Waters, Milford, CT, USA) coupled with SYNAPT G1HDMS system (Waters). Chromatographic separation was performed on an Acquity CSH C18 column (particle size of 1.7 μm, 2.1 mm × 100 mm; Waters). Column temperature was maintained at 55 °C. Chromasolv grade acetonitrile (ACN) and water solvents were obtained from Fluka (Sigma-Aldrich). For metabolite profiling, solvent A consisted of water :  ACN (60 : 40) with 10 mM ammonium formate (Sigma-Aldrich) and 0.1% formic acid (Sigma-Aldrich). Solvent B consisted of isopropanol (Sigma-Aldrich) : ACN (90 : 10) with 10 mM ammonium formate and 0.1% formic acid. The solvent gradient was as follows: 0–2 min, 40–43% solvent B; 2–2.1 min, 43–50% solvent B; 2.1–12 min, 50–54% solvent B; 12–12.1 min, 54–70% solvent B; 12.1–18 min, 70–99% solvent B; 18–20 min, 99–40% solvent B. A flow rate of 0.4 ml/min and an injected volume of 1.5 μl of sample were used in ESI+, and 3 μl of sample was used in ESI−. Mass spectrometric analysis was performed with the SYNAPT HDMS G1 system (Waters) in both ESI+ and ESI− modes. The capillary and cone voltage were set at 3000 V (2000 V in ESI− mode) and 30 V, respectively. The desolvation gas flow rate was set at 800 l/h. The desolvation and source temperatures were set at 400 and 100 °C, respectively. Mass spectrometric data were acquired over a range of m/z of 20–990 at rate of 0.1 per scan per second. Data were obtained in the centroid mode. The frequency of LockSpray was set at 0.5 s and corrected by averaging over 10 scans.

For data analysis, time-aligned ion features, mono-isotopic neutral mass, retention time as well and ion signal intensity were extracted from the raw data using the molecular feature extraction algorithm. MassLynx4.1 (Waters) and MetaboAnalyst were used for analysis and visualization of MS data sets in data metrices and PCA diagrams. Human Metabolome Database (http://www.hmdb.ca) and METLIN (http://metlin.scripps.edu/index.php) were used to search lipid metabolites. Candidates with high intensity were selected and validated by tandem mass spectrometry (MS/MS) with SYNAPT G1 HDMS system (Waters). Depending on the nature of compounds, the collision energy was ramped from 6 to 32 V. MS/MS spectra were acquired and confirmed by METLIN (http://metlin.scripps.edu/index.php) and LIPID MAPS (http://www.lipidmaps.org/). Metabolomic workflow of lipidomic profiling is listed in Supplementary Figure S3.

Calcium-independent phospholipase A2 (iPLA) activity

The iPLA activity was determined by using the cPLA2 assay kit (Cayman Chemical, Ann Arbor, MI, USA). C. elegans embryos obtained by bleach were re-suspended in 50 mM HEPES (pH 7.4) containing 1 mM EDTA 300 μl followed by sonication on ice (amplitude: 10%, 20 cycles of 2 s pulse and 5 s intervals) (Sonics and Materials, Newtown, CT, USA). The homogenates were centrifuged at 10 000 g for 15 min at 4 °C. The supernatants were collected for assay according to the manufacturer's protocol. The hydrolysis of the arachidonyl thio ester bond at the sn-2 position of synthetic substrate, arachidonyl thio-PC, releases a free thio, which can be detected by 5,5′-dithio-bis(2-nitrobenzoic acid) (DTNB). The activity of iPLA was determined in a calcium-free assay buffer (300 mM NaCl, 60% glycerol, 10 mM HEPES, 8 mM Triton X-100, 4 mM EGTA and 2 mg/ml of BSA). In brief, 10 μl of samples or a positive control (Bee venom PLA2) were incubated with 5 μl assay buffer. The reactions were initiated by adding 200 μl substrate solution and incubated for 1 h at room temperature followed by the addition of 10 μl of DTNB and incubation for 5 min at room temperature to stop reaction. The iPLA activity was calculated by the following formula and normalized for protein concentration:

graphic file with name cddis2016463e1.jpg

MDA assay

MDA was determined by using the Oxiselect thiobarbituric acid reactive substances assay kit (Cell Biolabs Inc., San Diego, CA, USA). About 28 mg of C. elegans embryos was suspended in PBS containing 0.05% butylated hydroxyl toluene followed by sonication on ice. The homogenate was centrifuged at 10 000 g for 5 min. The supernatant (worm lysates) was collected for assay according to the manufacturer's protocol. In brief, 100 μl of worm lysate or MDA standards were incubated with 100 μl SDS lysis solution in separate microcentrifuge tubes at room temperature for 5 min. Each sample and standards were incubated with 250 μl of 5.2 mg/ml TBA reagent (pH 3.5) at 95 °C for 60 min. The samples were placed in an ice bath for 5 min and centrifuged at 3000  r.p.m. for 15 min. The 200 μl of supernatant of MDA standards or samples were transferred to a 96-well microplate and read by the absorbance spectroscopy at 532 nm. The MDA content in samples was determined by using the MDA standard curve. The results were normalized with the corresponding sample weight.

NADPH measurement

The NADPH extraction method was modified from a previous protocol.55 C. elegans was collected and washed by M9 buffer on ice followed by transfer of the pellet into 2 ml Percellys tube (Bertin Technologies, Montigny-le-Bretonneux, France). Each tube was pre-filled with 100 μl of 1 mm Ziconia beads (BioSpec Products, Bartlesville, OK, USA) and 1 ml of the extraction solvent containing 80% methanol (J.T.Baker) with 10 mM KOH which pre-cooled on ice. Samples were snap frozen in liquid nitrogen for 5 min and homogenized by Percellys 24 (Bertin Technologies) (6500  r.p.m., 30 s for two times, interval 5 s) at 4 °C. Samples were then held on ice for 15 min and centrifuged at 12 000  r.p.m., 4 °C for 15 min (Eppendorf). Supernatants were transferred to 15 mm × 45 mm screw thread clear vials (Thermo Fisher Scientific, Waltham, MA, USA) and pellets were re-extracted with 1 ml extraction solvent. Supernatant were air dried by nitrogen gas and stored at −80 °C. Re-suspended pellet with 300 μl of water (Fluka) and centrifuged at 12 000  r.p.m. for 30 min for analysis. Samples were analyzed by UPLC equipped with a photodiode array detector (Waters). Samples were chromatographed on an Acquity HSST3 reversed-phase C18 column (particle size of 1.8 μm, 2.1 mm × 150 mm; Waters). The composition of the mobile phase contained 25 mM potassium monobasic phosphate buffer (pH 6.0) (solvent A) and 100% methanol (solvent B) (J.T.Baker). The gradient was as follows: 0–2 min, 0% solvent B; 2–2.5 min, 0–3% solvent B; 2.5–5 min, 3–4% solvent B; 5–7 min, 4–15% solvent B; 7–8 min, 15% solvent B; 8–9 min, 15–0% solvent B; 9–11 min, 0% solvent B. The column temperature was maintained at 37 °C. The flow rate was set at 0.38 ml/min and an injected volume of 3 μl of sample was used. Absorbance spectra were acquired from the wavelength at 260 and 340 nm. The NADPH contents were normalized by the protein concentration of the pellets. The protein was extracted by incubating pellets with 1 ml of 0.1 N NaOH at 65 °C for 30 min followed by determining protein concentration (Bradford).

Statistical analysis

The LC-MS raw data were initially analyzed by Markerlynx (Waters). For modeling and reporting metabolomic data, the unsupervised PCA and orthogonal partial least-squares discriminant analysis (OPLS-DA) model and the Extended Statistics (EZinfo, Waters) were used. The variable importance in the projection (VIP) value of each variable in the model was calculated to represent its contribution to the grouping. A higher VIP value indicated a stronger contribution to discrimination among groups. Where applicable, presenting data were shown as mean±S.D. Statistical difference between mock and G6PD-deficient adults and embryos was analyzed by two-tailed t-test. Statistical tests were conducted using GraphPad Prism 6.0 (GraphPad Software, San Diego, CA, USA). Values of P<0.05 were considered statistically significant.

Acknowledgments

The reporter strain OD344 was kindly provided by Prof. Olson (Department of Biology, Pomona College, USA). This work was made possible by grants from the Ministry of Science and Technology of Taiwan (MOST103-2320-B-182-026-MY2 and MOST105-2320-B-182-031-MY2 to DTYC; MOST103-2320-B-182-020 and MOST104-2320-B-182-017-MY3 to MLC), from the Ministry of Education of Taiwan (EMRPD1E1651, EMRPD1F0261 and EMRPD1F0361 to DTYC; EMRPD1E1721 and EMRPD1F0331 to MLC; EMRPD1D0651, EMRPD1E1431 and EMRPD1F0061 to SJL), and from Chang Gung Memorial Hospital (BMRP098, CMRPD1C0772, CMRPD1C0773, CMRPD3D0161 and CMRPD3D0162 to DTYC; BMRP564, CMRPD1C0442, CMRPD1C0443, CMRPD1C0762, CMRPD1C0763 and CMRPD1F0511 to MLC and BMRP742 to SJL).

Author contributions

TLC and HCY designed, performed experiments and wrote the first draft of manuscript; CYH performed the lipidomic profiling experiments; MHO performed the polarity experiments; YYP assisted in nematode culture, RNAi silencing and lipid extraction; MLC and AS assisted in interpreting results and writing the manuscript; and SJL and DTYC conceived the overall design and wrote the final version of manuscript.

Footnotes

Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)

Edited by A Finazzi-Agro'

The authors declare no conflict of interest.

Supplementary Material

Supplementary Figure S1
Click here for additional data file. (3.8MB, tif)
Supplementary Figure S2
Click here for additional data file. (2MB, tif)
Supplementary Figure S3
Click here for additional data file. (1.3MB, tif)
Supplementary Figure S4
Click here for additional data file. (1.7MB, tif)
Supplementary Figure S5
Click here for additional data file. (1.8MB, tif)
Supplementary Tables
Click here for additional data file. (219.5KB, doc)
Supplementary Table and Figure Legends
Click here for additional data file. (16.4KB, docx)

References

  1. Luzzatto L. G6PD deficiency: a polymorphism balanced by heterozygote advantage against malaria. Lancet Haematol 2015; 2: e400–e401. [DOI] [PubMed] [Google Scholar]
  2. Yang HC, Wu YH, Liu HY, Stern A, Chiu DT. What has passed is prolog: new cellular and physiological roles of G6PD. Free Radic Res 2016; 50: 1047–1064. [DOI] [PubMed] [Google Scholar]
  3. Luzzatto L, Seneca E. G6PD deficiency: a classic example of pharmacogenetics with on-going clinical implications. Br J Haematol 2014; 164: 469–480. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Mazieres S, Petit F, Dugoujon JM, Iriart X, Berry A, Carme B et al. Subtle adjustments of the glucose-6-phosphate dehydrogenase (G6PD) mutation database and reference sequence. Blood Cells Mol Dis 2014; 52: 55–56. [DOI] [PubMed] [Google Scholar]
  5. Longo L, Vanegas OC, Patel M, Rosti V, Li H, Waka J et al. Maternally transmitted severe glucose 6-phosphate dehydrogenase deficiency is an embryonic lethal. EMBO J 2002; 21: 4229–4239. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Nicol CJ, Zielenski J, Tsui LC, Wells PG. An embryoprotective role for glucose-6-phosphate dehydrogenase in developmental oxidative stress and chemical teratogenesis. FASEB J 2000; 14: 111–127. [DOI] [PubMed] [Google Scholar]
  7. Yang HC, Chen TL, Wu YH, Cheng KP, Lin YH, Cheng ML et al. Glucose 6-phosphate dehydrogenase deficiency enhances germ cell apoptosis and causes defective embryogenesis in Caenorhabditis elegans. Cell Death Dis 2013; 4: e616. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Paglialunga F, Fico A, Iaccarino I, Notaro R, Luzzatto L, Martini G et al. G6PD is indispensable for erythropoiesis after the embryonic-adult hemoglobin switch. Blood 2004; 104: 3148–3152. [DOI] [PubMed] [Google Scholar]
  9. Fico A, Paglialunga F, Cigliano L, Abrescia P, Verde P, Martini G et al. Glucose-6-phosphate dehydrogenase plays a crucial role in protection from redox-stress-induced apoptosis. Cell Death Differ 2004; 11: 823–831. [DOI] [PubMed] [Google Scholar]
  10. Filosa S, Fico A, Paglialunga F, Balestrieri M, Crooke A, Verde P et al. Failure to increase glucose consumption through the pentose-phosphate pathway results in the death of glucose-6-phosphate dehydrogenase gene-deleted mouse embryonic stem cells subjected to oxidative stress. Biochem J 2003; 370(Pt 3): 935–943. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Patrinostro X, Carter ML, Kramer AC, Lund TC. A model of glucose-6-phosphate dehydrogenase deficiency in the zebrafish. Exp Hematol 2013; 41: 697–710 e692. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Chirala SS, Chang H, Matzuk M, Abu-Elheiga L, Mao J, Mahon K et al. Fatty acid synthesis is essential in embryonic development: fatty acid synthase null mutants and most of the heterozygotes die in utero. Proc Natl Acad Sci USA 2003; 100: 6358–6363. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Rappleye CA, Tagawa A, Le Bot N, Ahringer J, Aroian RV. Involvement of fatty acid pathways and cortical interaction of the pronuclear complex in Caenorhabditis elegans embryonic polarity. BMC Dev Biol 2003; 3: 8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Wang L, Magdaleno S, Tabas I, Jackowski S. Early embryonic lethality in mice with targeted deletion of the CTP:phosphocholine cytidylyltransferase alpha gene (Pcyt1a). Mol Cell Biol 2005; 25: 3357–3363. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Wu G, Aoyama C, Young SG, Vance DE. Early embryonic lethality caused by disruption of the gene for choline kinase alpha, the first enzyme in phosphatidylcholine biosynthesis. J Biol Chem 2008; 283: 1456–1462. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Wenk MR. Lipidomics: new tools and applications. Cell 2010; 143: 888–895. [DOI] [PubMed] [Google Scholar]
  17. Hishikawa D, Hashidate T, Shimizu T, Shindou H. Diversity and function of membrane glycerophospholipids generated by the remodeling pathway in mammalian cells. J Lipid Res 2014; 55: 799–807. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Schaloske RH, Dennis EA. The phospholipase A2 superfamily and its group numbering system. Biochim Biophys Acta 2006; 1761: 1246–1259. [DOI] [PubMed] [Google Scholar]
  19. Ramanadham S, Ali T, Ashley JW, Bone RN, Hancock WD, Lei X. Calcium-independent phospholipases A2 and their roles in biological processes and diseases. J Lipid Res 2015; 56: 1643–1668. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Dennis EA, Cao J, Hsu YH, Magrioti V, Kokotos G. Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention. Chem Rev 2011; 111: 6130–6185. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Olson SK, Greenan G, Desai A, Muller-Reichert T, Oegema K. Hierarchical assembly of the eggshell and permeability barrier in C. elegans. J Cell Biol 2012; 198: 731–748. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Tagawa A, Rappleye CA, Aroian RV. Pod-2, along with pod-1, defines a new class of genes required for polarity in the early Caenorhabditis elegans embryo. Dev Biol 2001; 233: 412–424. [DOI] [PubMed] [Google Scholar]
  23. Kniazeva M, Shen H, Euler T, Wang C, Han M. Regulation of maternal phospholipid composition and IP(3)-dependent embryonic membrane dynamics by a specific fatty acid metabolic event in C. elegans. Genes Dev 2012; 26: 554–566. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Vrablik TL, Watts JL. Polyunsaturated fatty acid derived signaling in reproduction and development: insights from Caenorhabditis elegans and Drosophila melanogaster. Mol Reprod Dev 2013; 80: 244–259. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Morrison K, Witte K, Mayers JR, Schuh AL, Audhya A. Roles of acidic phospholipids and nucleotides in regulating membrane binding and activity of a calcium-independent phospholipase A2 isoform. J Biol Chem 2012; 287: 38824–38834. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Ivanova PT, Milne SB, Byrne MO, Xiang Y, Brown HA. Glycerophospholipid identification and quantitation by electrospray ionization mass spectrometry. Methods Enzymol 2007; 432: 21–57. [DOI] [PubMed] [Google Scholar]
  27. Shindou H, Hishikawa D, Harayama T, Yuki K, Shimizu T. Recent progress on acyl CoA: lysophospholipid acyltransferase research. J Lipid Res 2009; 50(Suppl): S46–S51. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Murakami M, Taketomi Y, Miki Y, Sato H, Hirabayashi T, Yamamoto K. Recent progress in phospholipase A(2) research: from cells to animals to humans. Prog Lipid Res 2011; 50: 152–192. [DOI] [PubMed] [Google Scholar]
  29. Leslie CC. Cytosolic phospholipase A(2): physiological function and role in disease. J Lipid Res 2015; 56: 1386–1402. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Rashba-Step J, Tatoyan A, Duncan R, Ann D, Pushpa-Rehka TR, Sevanian A. Phospholipid peroxidation induces cytosolic phospholipase A2 activity: membrane effects versus enzyme phosphorylation. Arch Biochem Biophys 1997; 343: 44–54. [DOI] [PubMed] [Google Scholar]
  31. Tsouko E, Khan AS, White MA, Han JJ, Shi Y, Merchant FA et al. Regulation of the pentose phosphate pathway by an androgen receptor-mTOR-mediated mechanism and its role in prostate cancer cell growth. Oncogenesis 2014; 3: e103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Patra KC, Hay N. The pentose phosphate pathway and cancer. Trends Biochem Sci 2014; 39: 347–354. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Nogae I, Johnston M. Isolation and characterization of the ZWF1 gene of Saccharomyces cerevisiae, encoding glucose-6-phosphate dehydrogenase. Gene 1990; 96: 161–169. [DOI] [PubMed] [Google Scholar]
  34. Thomas D, Cherest H, Surdin-Kerjan Y. Identification of the structural gene for glucose-6-phosphate dehydrogenase in yeast. Inactivation leads to a nutritional requirement for organic sulfur. EMBO J 1991; 10: 547–553. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Grabowska D, Chelstowska A. The ALD6 gene product is indispensable for providing NADPH in yeast cells lacking glucose-6-phosphate dehydrogenase activity. J Biol Chem 2003; 278: 13984–13988. [DOI] [PubMed] [Google Scholar]
  36. Kniazeva M, Zhu H, Sewell AK, Han M. A lipid-TORC1 pathway promotes neuronal development and foraging behavior under both fed and fasted conditions in C. elegans. Dev Cell 2015; 33: 260–271. [DOI] [PubMed] [Google Scholar]
  37. Shi X, Tarazona P, Brock TJ, Browse J, Feussner I, Watts JL. A Caenorhabditis elegans model for ether lipid biosynthesis and function. J Lipid Res 2016; 57: 265–275. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Vrablik TL, Watts JL. Emerging roles for specific fatty acids in developmental processes. Genes Dev 2012; 26: 631–637. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Satouchi K, Hirano K, Sakaguchi M, Takehara H, Matsuura F. Phospholipids from the free-living nematode Caenorhabditis elegans. Lipids 1993; 28: 837–840. [DOI] [PubMed] [Google Scholar]
  40. Watts JL, Browse J. Genetic dissection of polyunsaturated fatty acid synthesis in Caenorhabditis elegans. Proc Natl Acad Sci USA 2002; 99: 5854–5859. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Sato M, Grant BD, Harada A, Sato K. Rab11 is required for synchronous secretion of chondroitin proteoglycans after fertilization in Caenorhabditis elegans. J Cell Sci 2008; 121(Pt 19): 3177–3186. [DOI] [PubMed] [Google Scholar]
  42. Olson SK, Bishop JR, Yates JR, Oegema K, Esko JD. Identification of novel chondroitin proteoglycans in Caenorhabditis elegans: embryonic cell division depends on CPG-1 and CPG-2. J Cell Biol 2006; 173: 985–994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Kahn-Kirby AH, Dantzker JL, Apicella AJ, Schafer WR, Browse J, Bargmann CI et al. Specific polyunsaturated fatty acids drive TRPV-dependent sensory signaling in vivo. Cell 2004; 119: 889–900. [DOI] [PubMed] [Google Scholar]
  44. Winrow CJ, Hemming ML, Allen DM, Quistad GB, Casida JE, Barlow C. Loss of neuropathy target esterase in mice links organophosphate exposure to hyperactivity. Nat Genet 2003; 33: 477–485. [DOI] [PubMed] [Google Scholar]
  45. Moser M, Li Y, Vaupel K, Kretzschmar D, Kluge R, Glynn P et al. Placental failure and impaired vasculogenesis result in embryonic lethality for neuropathy target esterase-deficient mice. Mol Cell Biol 2004; 24: 1667–1679. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Tang HY, Ho HY, Wu PR, Chen SH, Kuypers FA, Cheng ML et al. Inability to maintain GSH pool in G6PD-deficient red cells causes futile AMPK activation and irreversible metabolic disturbance. Antioxid Redox Signal 2015; 22: 744–759. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Agostini M, Annicchiarico-Petruzzelli M, Melino G, Rufini A. Metabolic pathways regulated by TAp73 in response to oxidative stress. Oncotarget 2016; 7: 29881–29900. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Agostini M, Romeo F, Inoue S, Niklison-Chirou MV, Elia AJ, Dinsdale D et al. Metabolic reprogramming during neuronal differentiation. Cell Death Differ 2016; 23: 1502–1514. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. McLean LR, Hagaman KA, Davidson WS. Role of lipid structure in the activation of phospholipase A2 by peroxidized phospholipids. Lipids 1993; 28: 505–509. [DOI] [PubMed] [Google Scholar]
  50. Salgo MG, Corongiu FP, Sevanian A. Peroxidation and phospholipase A2 hydrolytic susceptibility of liposomes consisting of mixed species of phosphatidylcholine and phosphatidylethanolamine. Biochim Biophys Acta 1992; 1127: 131–140. [DOI] [PubMed] [Google Scholar]
  51. Domijan AM, Kovac S, Abramov AY. Lipid peroxidation is essential for phospholipase C activity and the inositol-trisphosphate-related Ca(2)(+) signal. J Cell Sci 2014; 127(Pt 1): 21–26. [DOI] [PubMed] [Google Scholar]
  52. Wratten ML, van Ginkel G, van't Veld AA, Bekker A, van Faassen EE, Sevanian A. Structural and dynamic effects of oxidatively modified phospholipids in unsaturated lipid membranes. Biochemistry 1992; 31: 10901–10907. [DOI] [PubMed] [Google Scholar]
  53. Pacifici EH, McLeod LL, Sevanian A. Lipid hydroperoxide-induced peroxidation and turnover of endothelial cell phospholipids. Free Radic Biol Med 1994; 17: 297–309. [DOI] [PubMed] [Google Scholar]
  54. Freikman I, Ringel I, Fibach E. Oxidative stress-induced membrane shedding from RBCs is Ca flux-mediated and affects membrane lipid composition. J Membr Biol 2011; 240: 73–82. [DOI] [PubMed] [Google Scholar]
  55. Ho HY, Cheng ML, Shiao MS, Chiu DT. Characterization of global metabolic responses of glucose-6-phosphate dehydrogenase-deficient hepatoma cells to diamide-induced oxidative stress. Free Radic Biol Med 2013; 54: 71–84. [DOI] [PubMed] [Google Scholar]
  56. Girard LR, Fiedler TJ, Harris TW, Carvalho F, Antoshechkin I, Han M et al. WormBook: the online review of Caenorhabditis elegans biology. Nucleic Acids Res 2007; 35(Database issue): D472–D475. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Fraser AG, Kamath RS, Zipperlen P, Martinez-Campos M, Sohrmann M, Ahringer J. Functional genomic analysis of C. elegans chromosome I by systematic RNA interference. Nature 2000; 408: 325–330. [DOI] [PubMed] [Google Scholar]
  58. Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 1957; 226: 497–509. [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary Figure S1
Click here for additional data file. (3.8MB, tif)
Supplementary Figure S2
Click here for additional data file. (2MB, tif)
Supplementary Figure S3
Click here for additional data file. (1.3MB, tif)
Supplementary Figure S4
Click here for additional data file. (1.7MB, tif)
Supplementary Figure S5
Click here for additional data file. (1.8MB, tif)
Supplementary Tables
Click here for additional data file. (219.5KB, doc)
Supplementary Table and Figure Legends
Click here for additional data file. (16.4KB, docx)

Articles from Cell Death & Disease are provided here courtesy of Nature Publishing Group

RESOURCES